Revolutionizing

ReGen Factor’s groundbreaking blood substitute technology, is in development to save lives in critical environments such as battlefields and emergency situations. Join us in transforming trauma care.

Revolutionary Blood Substitute Technology

Our research is working towards these goals and with over 10 million Monte Carlo trials, we have found that the likelihood of success is close to 98 percent.

Molecular Structure

This diagram showcases the unique molecular design of our blood substitute, highlighting its stability and efficacy in various conditions.

Learn More

A battlefield medic using HemoGuard's blood substitute in a critical situation.

Battlefield Application

Our technology is designed to be used in extreme conditions, providing a reliable solution for medics in the field.

Learn More

A chart comparing the efficacy of HemoGuard's blood substitute with traditional blood transfusions.

Efficacy Comparison

This chart demonstrates the superior performance of our blood substitute in terms of stability and effectiveness.

Learn More

Explore the Versatile Applications of VivoBlood Technology

VivoBlood: ReGen Factor is developing a multitude of applications, from supporting PFAS detoxification and trauma care to serving as a surgical alternative and aiding cancer treatment. Its unique properties make it an invaluable asset in various critical medical scenarios, ensuring enhanced patient outcomes and streamlined healthcare delivery.

A medical professional in a sterile lab coat examining a blood sample under a microscope, with vials of HemoGuard-Safe nearby, symbolizing PFAS exposure support and clinical detoxification.

PFAS Exposure Support

Aids in clinical detoxification from PFAS toxins, potentially removing them from the bloodstream and protecting organs from systemic damage. ReGen Factor is implementing a proactive approach to mitigating the harmful effects of PFAS exposure.

Learn More

A group of military medics tending to a wounded soldier on a battlefield, with HemoGuard-Safe being administered intravenously, highlighting its trauma and emergency use.

Trauma & Emergency Use

Being developed to be ideal for military and civilian trauma care due to its long shelf life, universal compatibility, and ability to replace lost blood in critical situations. VivoBlood is a in development as reliable solution in critical moments.

Learn More

A surgeon in an operating room preparing for a transfusion, with a clear bag of HemoGuard-Safe prominently displayed, emphasizing its use as a surgical and transfusion alternative.

Surgical Alternative

VivoBlood could in the future be used in hospitals when blood is unavailable or unsuitable, offering safe, infection-free transfusion support without blood-type matching. VivoBlood may ensure patient safety and efficient medical procedures.

Learn More

PFAS Exposure Support

In development to aid clinical detoxification from PFAS toxins, potentially removing them from the bloodstream and protecting organs from systemic damage.

Trauma & Emergency Use

Ideal for military and civilian trauma care due to its long shelf life, universal compatibility, and ability to replace lost blood in critical situations.

Surgical & Transfusion Alternative

To be used in hospitals when blood is unavailable or unsuitable, offering safe, infection-free transfusion support without blood-type matching.

Cancer & Hematologic Treatment

In development to support blood function in patients undergoing chemotherapy or bone marrow transplants, especially in cases of anemia or immune compromise.

Get in Touch

For inquiries, partnerships, or to learn more about our groundbreaking blood substitute technology, please contact us at [email protected] or
Call us at+61 2 9000 1042
Our team is dedicated to advancing trauma care and saving lives in critical environments.

Visit Us

ReGen Factor Offices: 14/117 Old Pittwater Road, Brookvale, NSW 2100